SCHEMBL3369666

SCHEMBL3369666

O=CCNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25697034 0.89
SCHEMBL7436238 0.89
SCHEMBL8184317 0.87 DPP7 (0.52)
SCHEMBL7473497 0.83 DPP7 (0.31)
SCHEMBL2297128 0.79 EPHX2 (0.34)
SCHEMBL19753009 0.76 EPHX1 (0.40)
SCHEMBL15715697 0.75 DPP7 (0.39)
SCHEMBL4019293 0.74
SCHEMBL29427825 0.74
Hydrochloric Acid SCHEMBL15670961 0.73 DPP7 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190289-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS Intervet International B.V. (NL) 2010-06-02 EP claimed
WO-2009024541-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. (NL) 2009-02-26 WO claimed
EP-3473101-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS FOR FELINES Intervet International B.V. (NL) 2019-04-24 EP disclosed
EP-2417140-B1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INT (DE) 2014-11-26 EP disclosed
EP-2190289-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS Intervet International B.V. (NL) 2010-06-02 EP disclosed
WO-2009024541-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. (NL) 2009-02-26 WO disclosed
US-5864043-A CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST KARL THOMAE GMBH (DE) 1999-01-26 US disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed